staehler gerd sigmund pomer (22 risultati)

Condizione: Good. 158 pp., Hardcover, ex library, else text clean and binding tight. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.

Condizione: New. In.

Condizione: New. In.

Paperback. Condizione: Brand New. reprint edition. 170 pages. 9.06x5.98x0.39 inches. In Stock.

Paperback. Condizione: Brand New. reprint edition. 249 pages. 9.25x6.10x0.60 inches. In Stock.

Taschenbuch. Condizione: Neu. Basic and Clinical Research on Renal Cell Carcinoma | Gerd Staehler (u. a.) | Taschenbuch | XII | Englisch | 2011 | Springer | EAN 9783642768651 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Condizione: Neu. Contemporary Research on Renal Cell Carcinoma | Basic and Clinical Developments | Gerd Staehler (u. a.) | Taschenbuch | xii | Englisch | 2011 | Springer | EAN 9783642786112 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Condizione: Neu. Neuware -Advanced Renal Cell Carcinoma (RCC) cannot be cured bysurgery alone. Its resillience to irradiation andchemotherapy demands a new approach to the management ofthis disease.This bookprovides an overview of the scientific and clinicaldevelopments of RCCand clarifies the fields ofimmunotherapy andimmunobiology.The book contains a compilation of approaches that willenhance the effectiveness of the management of advancedRCCeven in the absence of definitive pre-clinical data. Theserequire additional study and will stimulate the reassessmentof preliminary results.Furthermore, preliminary resultsof already implemented clinical trials withbiologicalmodifiers are presented. Of special interest are the currentachievements in thefield of immunotherapy using topically and subcutaneouslylow dosage combinations of cytokines.This concise volumewill benefit those seeking a thorough review of the researchand the clinical aspects of RCC simultaneously.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 256 pp. Englisch.

Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - The management of advanced renal cell carcinoma is still problematic. Surgery, although the therapy of choice for locally advanced renal tumors, is still controversial as the treatment for metastases. The role of surgery in the management of patients with pulmonary, bony, and liver metastasis is one of the subject matters discussed in this book. Our results with series of patients undergoing resection of metastases from the lung, bone, and liver show that surgery may be appropriate in selected patients with a good performance status, although most of them certainly cannot be cured by this procedure alone, i.e., in the absence of effective adjuvant therapies. As recent developments show, new strategies for immunotherapy of renal cell carcinoma represent a modest advance over traditional approaches in the treatment of this cancer, such as chemo- and radiotherapy. Clinical trials employing recombinant interferon-a and interleukin 2 produced response rates in up to 30% of patients treated, as evidenced by the European Immunotherapy Trials Program. The adverse reactions and the lack of efficacy in the majority of patients warrants the search for new immunotherapeutic approaches.

Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Advanced Renal Cell Carcinoma (RCC) cannot be cured bysurgery alone. Its resillience to irradiation andchemotherapy demands a new approach to the management ofthis disease.This bookprovides an overview of the scientific and clinicaldevelopments of RCC,and clarifies the fields ofimmunotherapy andimmunobiology.The book contains a compilation of approaches that willenhance the effectiveness of the management of advancedRCC,even in the absence of definitive pre-clinical data. Theserequire additional study and will stimulate the reassessmentof preliminary results.Furthermore, preliminary resultsof already implemented clinical trials withbiologicalmodifiers are presented. Of special interest are the currentachievements in thefield of immunotherapy using topically and subcutaneouslylow dosage combinations of cytokines.This concise volumewill benefit those seeking a thorough review of the researchand the clinical aspects of RCC simultaneously.

Unbekannt. Condizione: Sehr gut. 237 S. Advanced Renal Cell Carcinoma (RCC) cannot be cured bysurgery alone. Its resillience to irradiation andchemotherapy demands a new approach to the management ofthis disease.This bookprovides an overview of the scientific and clinicaldevelopments of RCC,and clarifies the fields ofimmunotherapy andimmunobiology.The book contains a compilation of approaches that willenhance the effectiveness of the management of advancedRCC,even in the absence of definitive pre-clinical data. Theserequire additional study and will stimulate the reassessmentof preliminary results.Furthermore, preliminary resultsof already implemented clinical trials withbiologicalmodifiers are presented. Of special interest are the currentachievements in thefield of immunotherapy using topically and subcutaneouslylow dosage combinations of cytokines.This concise volumewill benefit those seeking a thorough review of the researchand the clinical aspects of RCC simultaneously. Sprache: Englisch Gewicht in Gramm: 534.

hardcover. Condizione: Very Good. Very Good. Dust Jacket may NOT BE INCLUDED.CDs may be missing. SHIPS FROM MULTIPLE LOCATIONS. book.

Paperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Paperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condizione: new. Questo è un articolo print on demand.

Condizione: new. Questo è un articolo print on demand.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The management of advanced renal cell carcinoma is still problematic. Surgery, although the therapy of choice for locally advanced renal tumors, is still controversial as the treatment for metastases. The role of surgery in the management of patients with pulmonary, bony, and liver metastasis is one of the subject matters discussed in this book. Our results with series of patients undergoing resection of metastases from the lung, bone, and liver show that surgery may be appropriate in selected patients with a good performance status, although most of them certainly cannot be cured by this procedure alone, i.e., in the absence of effective adjuvant therapies. As recent developments show, new strategies for immunotherapy of renal cell carcinoma represent a modest advance over traditional approaches in the treatment of this cancer, such as chemo- and radiotherapy. Clinical trials employing recombinant interferon-a and interleukin 2 produced response rates in up to 30% of patients treated, as evidenced by the European Immunotherapy Trials Program. The adverse reactions and the lack of efficacy in the majority of patients warrants the search for new immunotherapeutic approaches. 176 pp. Englisch.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Advanced Renal Cell Carcinoma (RCC) cannot be cured bysurgery alone. Its resillience to irradiation andchemotherapy demands a new approach to the management ofthis disease.This bookprovides an overview of the scientific and clinicaldevelopments of RCC,and clarifies the fields ofimmunotherapy andimmunobiology.The book contains a compilation of approaches that willenhance the effectiveness of the management of advancedRCC,even in the absence of definitive pre-clinical data. Theserequire additional study and will stimulate the reassessmentof preliminary results.Furthermore, preliminary resultsof already implemented clinical trials withbiologicalmodifiers are presented. Of special interest are the currentachievements in thefield of immunotherapy using topically and subcutaneouslylow dosage combinations of cytokines.This concise volumewill benefit those seeking a thorough review of the researchand the clinical aspects of RCC simultaneously. 256 pp. Englisch.

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. With Contributions by numerous expertsAdvanced Renal Cell Carcinoma (RCC) cannot be cured bysurgery alone. Its resillience to irradiation andchemotherapy demands a new approach to the management ofthis disease.This bookprovides an overview of the .

Condizione: New. Print on Demand pp. xii + 158 61 Figures, 3 Illus. (Col.).

Condizione: New. PRINT ON DEMAND pp. xii + 158.

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The management of advanced renal cell carcinoma is still problematic. Surgery, although the therapy of choice for locally advanced renal tumors, is still controversial as the treatment for metastases. The role of surgery in the management of patients with pulmonary, bony, and liver metastasis is one of the subject matters discussed in this book. Our results with series of patients undergoing resection of metastases from the lung, bone, and liver show that surgery may be appropriate in selected patients with a good performance status, although most of them certainly cannot be cured by this procedure alone, i.e., in the absence of effective adjuvant therapies. As recent developments show, new strategies for immunotherapy of renal cell carcinoma represent a modest advance over traditional approaches in the treatment of this cancer, such as chemo- and radiotherapy. Clinical trials employing recombinant interferon-a and interleukin 2 produced response rates in up to 30% of patients treated, as evidenced by the European Immunotherapy Trials Program. The adverse reactions and the lack of efficacy in the majority of patients warrants the search for new immunotherapeutic approaches.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 176 pp. Englisch.